Literature DB >> 28084957

Hypertrophic cardiomyopathy.

Maully Shah1.   

Abstract

Hypertrophic cardiomyopathy is a common, inherited heart disease with a heterogeneous clinical presentation and natural history. Recently, advances in diagnosis and treatment options have been instrumental in decreasing the frequency of adverse clinical events; however, complete elimination of sudden cardiac death still remains an elusive gain. This article discusses several aspects of this condition in the young: epidemiology, clinical phenotypes, risk factors, prevention of sudden cardiac death, and risks of athletic participation.

Entities:  

Keywords:  Hypertrophic cardiomyopathy; athletes; children; sudden death

Mesh:

Year:  2017        PMID: 28084957     DOI: 10.1017/S1047951116002195

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  8 in total

1.  Apical hypertrophic cardiomyopathy, are low-risk patients really at low risk? A case report.

Authors:  Rui Files Flores; Fernando Mané; Nuno Antunes; Vítor Hugo Pereira
Journal:  Eur Heart J Case Rep       Date:  2020-09-23

2.  Signal-to-Noise Analysis Can Inform the Likelihood That Incidentally Identified Variants in Sarcomeric Genes Are Associated with Pediatric Cardiomyopathy.

Authors:  Leonie M Kurzlechner; Edward G Jones; Amy M Berkman; Hanna J Tadros; Jill A Rosenfeld; Yaping Yang; Hari Tunuguntla; Hugh D Allen; Jeffrey J Kim; Andrew P Landstrom
Journal:  J Pers Med       Date:  2022-04-30

3.  Systemic Lupus Erythematosus Complicated with Hypertrophic Cardiomyopathy: A Case Report and Literature Review.

Authors:  Huihui Ma; Xin Cao; Jing Zhang; Yongmei Zhou; Rong Luo; Tao He; Jianhong Tao; Xiaoping Li
Journal:  Case Rep Cardiol       Date:  2021-04-11

4.  Dysfunctional Network and Mutation Genes of Hypertrophic Cardiomyopathy.

Authors:  Yunwen Cui; Cheng Liu; Jian Luo; Jie Liang
Journal:  J Healthc Eng       Date:  2022-01-28       Impact factor: 2.682

5.  Susceptibility Modules and Genes in Hypertrophic Cardiomyopathy by WGCNA and ceRNA Network Analysis.

Authors:  Yifan Sun; Zhongbo Xiao; Yequn Chen; Duanmin Xu; Shuying Chen
Journal:  Front Cell Dev Biol       Date:  2022-02-01

Review 6.  Bacterial Cellulose and ECM Hydrogels: An Innovative Approach for Cardiovascular Regenerative Medicine.

Authors:  Izabela Gabriela Rodrigues da Silva; Bruna Tássia Dos Santos Pantoja; Gustavo Henrique Doná Rodrigues Almeida; Ana Claudia Oliveira Carreira; Maria Angélica Miglino
Journal:  Int J Mol Sci       Date:  2022-04-02       Impact factor: 5.923

7.  Retrospective analysis of clinical phenotype and prognosis of hypertrophic cardiomyopathy complicated with hypertension.

Authors:  Qin Luo; Jin Chen; Tianhua Zhang; Xiaoyu Tang; Bilian Yu
Journal:  Sci Rep       Date:  2020-01-15       Impact factor: 4.379

8.  Quantitative Differentiation of Left Atrial Performance in Hypertrophic Cardiomyopathy: Comparison Between Nonobstruction and Occult Obstruction With 4-dimensional Volume-strain.

Authors:  Hong Ran; Matthias Schneider; Lin-Lin Wan; Jun-Yi Ren; Xiao-Wu Ma; Ping-Yang Zhang
Journal:  J Thorac Imaging       Date:  2022-01-01       Impact factor: 3.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.